AbbVie’s Acquisition of DJS Antibodies

Goodwin Procter advised DJS Antibodies on the deal. AbbVie (NYSE: ABBV) announced the acquisition of DJS Antibodies Ltd (“DJS”), a privately-held UK-based biotechnology company dedicated to discovering...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Satgana’s First Luxembourg Fund

CMS Luxembourg has advised Satgana on the deal. Satgana established its first Luxembourg fund, Satgana Fund I SCSp, and related vehicles, which will target long-term value...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here